Literature DB >> 1729176

Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.

D E Briles1, M J Crain, B M Gray, C Forman, J Yother.   

Abstract

The relationship between capsular type and virulence for mice was examined with 69 fresh human isolates of Streptococcus pneumoniae. These isolates represented eight capsular types or groups. Serologic and molecular weight differences in PspA (pneumococcal surface protein A) indicated that the strains were clonally distinct. Mice were infected intravenously with washed bacteria of all 69 isolates in sterile salt solutions. Twenty-eight of the isolates were also injected intraperitoneally to permit comparisons between the intravenous and intraperitoneal routes. With a few exceptions, there was concordance between the ability of strains to cause fatal infections by the two routes. About 30% of the 69 isolates were virulent for mice. The abilities of the isolates to kill mice and the length of time between inoculation and death were strongly associated with capsular type. All type 4 isolates, 40% of type 3 isolates, and 60% of group 6 isolates were virulent for mice; type 1 isolates were marginally virulent; and all type or group 14, 19, and 23 isolates were avirulent. Times to death were generally longer for mice infected with group 6 or type 1 than for those infected with type 3 or 4 pneumococci. There was no relationship between clinical diagnosis or tissue source of the isolates and virulence for mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729176      PMCID: PMC257510          DOI: 10.1128/iai.60.1.111-116.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  X-linked immune deficiency (xid) of CBA/N mice.

Authors:  L S Wicker; I Scher
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

2.  Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.

Authors:  M J Crain; W D Waltman; J S Turner; J Yother; D F Talkington; L S McDaniel; B M Gray; D E Briles
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

3.  Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916.

Authors:  D A Watson; D M Musher
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

4.  Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate.

Authors:  S Wallick; J L Claflin; D E Briles
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

5.  Role of intravascular replication in the pathogenesis of experimental bacteremia due to Haemophilus influenzae type b.

Authors:  L G Rubin; A Zwahlen; E R Moxon
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

6.  Protein serotyping of Streptococcus pneumoniae based on reactivity to six monoclonal antibodies.

Authors:  W D Waltman; L S McDaniel; B Andersson; L Bland; B M Gray; C S Eden; D E Briles
Journal:  Microb Pathog       Date:  1988-09       Impact factor: 3.738

7.  Clinical and epidemiologic studies of pneumococcal infection in children.

Authors:  B M Gray; H C Dillon
Journal:  Pediatr Infect Dis       Date:  1986 Mar-Apr

8.  Streptococcal group A carbohydrate has properties of both a thymus-independent (TI-2) and a thymus-dependent antigen.

Authors:  D E Briles; M Nahm; T N Marion; R M Perlmutter; J M Davie
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

9.  Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).

Authors:  L S McDaniel; J Yother; M Vijayakumar; L McGarry; W R Guild; D E Briles
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

10.  Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.

Authors:  L S McDaniel; G Scott; J F Kearney; D E Briles
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  135 in total

1.  Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice.

Authors:  E Azoulay-Dupuis; V Rieux; M Muffat-Joly; J P Bédos; E Vallée; C Rivier; R Isturiz; C Carbon; P Moine
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides.

Authors:  W R Usinger; A H Lucas
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Evolution and virulence of serogroup 6 pneumococci on a global scale.

Authors:  D Ashley Robinson; David E Briles; Marilyn J Crain; Susan K Hollingshead
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

4.  Contribution of a response regulator to the virulence of Streptococcus pneumoniae is strain dependent.

Authors:  Clare E Blue; Tim J Mitchell
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

5.  Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.

Authors:  Melanie Abeyta; Gail G Hardy; Janet Yother
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

6.  PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].

Authors:  Mirza Shaper; Susan K Hollingshead; William H Benjamin; David E Briles
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation.

Authors:  John T Wren; Lance K Blevins; Bing Pang; Lauren B King; Antonia C Perez; Kyle A Murrah; Jennifer L Reimche; Martha A Alexander-Miller; W Edward Swords
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

8.  Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Authors:  S Langermann; S R Palaszynski; J E Burlein; S Koenig; M S Hanson; D E Briles; C K Stover
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

9.  A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).

Authors:  Kristopher R Genschmer; Mary Ann Accavitti-Loper; David E Briles
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641

Review 10.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.